Collectively, these findings indicate that SESN2 enhances autophagy in prostate cancer cells by modulating key autophagy regulators, including ULK, LC3B, and p62, ultimately promoting autophagic activity. The gene discussed is MAP1LC3B; the disease is prostate cancer.